Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells.
about
Cytotoxic hydrophilic iminophosphorane coordination compounds of d⁸ metals. Studies of their interactions with DNA and HSA.Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production.Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Propertiesα2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK).NOXA as critical mediator for drug combinations in polychemotherapy.Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents.A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.Comparison of in vitro antileukemic activity of obatoclax and ABT-737.Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis.Transport and killing mechanism of a novel camptothecin-deoxycholic acid derivate on hepatocellular carcinoma cells.The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.Protective effect of plaunotol against doxorubicin-induced renal cell death.Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation.
P2860
Q30573290-55488B5C-330E-403C-94B9-C6FAE44D7B7BQ33812112-985CF647-F4F0-4E48-B51B-F0FB090B2330Q34541922-6DC0F9C3-946F-44EA-992B-172A6EDFDEF8Q35446994-2F55CF78-6722-40FF-A9EA-9AED23F767B4Q35961028-B11D11B9-16F3-41C9-91F1-CB98323CE93AQ36006896-FC057407-B1BE-4FF6-A432-5C3979F98D0FQ36071973-D266F976-25BF-4926-A541-565C0D3BBBDFQ36304307-F664CFE7-3163-4C48-BCE7-BEA6CBDB31ACQ38061861-48A96B42-CA11-44F5-B2E2-CB045BCA800FQ38793940-27593A34-FED2-4600-9CE2-178E643BDED6Q38974167-4CF8CF51-F768-49BE-A4B9-4D09B5C67F12Q39005112-568E866C-03EC-4EE7-B29E-F25FB06D1A0CQ39177637-FFE06323-5119-4247-B0F8-C50E628FDE80Q39321425-9A979EE1-1FBE-4C5E-BF0D-5A9F31E32ABFQ40947112-719D6E16-B354-48E1-9718-8DA86FF18008Q42087886-6B2D092F-D641-4283-8657-4C3C1FEA01DF
P2860
Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Different contribution of BH3- ...... p53-deficient leukemia cells.
@en
Different contribution of BH3- ...... p53-deficient leukemia cells.
@nl
type
label
Different contribution of BH3- ...... p53-deficient leukemia cells.
@en
Different contribution of BH3- ...... p53-deficient leukemia cells.
@nl
prefLabel
Different contribution of BH3- ...... p53-deficient leukemia cells.
@en
Different contribution of BH3- ...... p53-deficient leukemia cells.
@nl
P2093
P50
P1476
Different contribution of BH3- ...... n p53-deficient leukemia cells
@en
P2093
Alberto Anel
Javier Naval
Nuria López-Royuela
Patricia Pérez-Galán
P304
P356
10.1016/J.BCP.2010.02.010
P407
P577
2010-02-24T00:00:00Z